ÌÇÐÄÆƽâ°æ

Novo Nordisk

Statistics report about pharmaceutical company Novo Nordisk

This report presents key facts and figures about Danish biopharmaceutical company Novo Nordisk, the leading global company in diabetes treatment and care. This report shows the company's role in global pharma, its revenues, segments, and competitors.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Global positioning

6
  • Premium Statistic Pharmaceutical market size worldwide 2001-2029
  • Premium Statistic Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
  • Premium Statistic Leading 10 biotech and pharmaceutical companies based on market cap 2026
  • Premium Statistic Leading global biotech and pharmaceutical companies 2026, by net income
  • Premium Statistic Sales forecast of top-selling drugs worldwide 2030
  • Premium Statistic Ad spending of selected diabetes/weight loss drugs in the U.S. 2025

Key metrics

4
  • Basic Statistic Novo Nordisk net sales 2009-2025
  • Premium Statistic Novo Nordisk net profit 2009-2025
  • Premium Statistic R&D costs of Novo Nordisk 2018-2025
  • Basic Statistic Novo Nordisk total assets 2021-2025

Segments

4
  • Premium Statistic Novo Nordisk sales share by therapy area 2021-2025
  • Premium Statistic Novo Nordisk sales by therapy area 2022-2025
  • Basic Statistic Novo Nordisk sales in diabetes subsegments 2025
  • Premium Statistic Novo Nordisk sales share by region 2025

Competitors

5
  • Premium Statistic Eli Lilly's total revenue by segment 2022-2025
  • Premium Statistic Sanofi pharmaceutical segment revenues by product group 2025
  • Basic Statistic AstraZeneca revenue by therapeutic area 2022-2025
  • Premium Statistic Boehringer Ingelheim's distribution of revenue 2016-2025, by business
  • Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2025

Diabetes & weight loss - a growing market

5
  • Premium Statistic Anti-obesity drugs market size worldwide 2025-2040
  • Premium Statistic Economic impact of high BMI as share of GDP worldwide in 2020 and forecasts to 2035
  • Premium Statistic Market share of leading weight loss drugs worldwide Q2 2024-Q1 2025
  • Basic Statistic Ozempic net sales of Novo Nordisk 2020-2025
  • Basic Statistic Wegovy sales of Novo Nordisk Q1 2022-Q1 2026
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch